Derm Forum: Practical Approaches to Advanced Therapy for Type 2 Inflammatory Skin Diseases
This activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.
Risk-Informed PAH Management: Practical Case Decisions from Early Detection to Treatment Escalation
This activity is supported by an educational grant from Merck & Co., Inc.
The Amylin Adventure: Amylin-Based Therapies for Obesity
This activity is supported by an educational grant from Novo Nordisk, Inc.
Unifying Evolving Paradigms in MS: From Early Diagnosis to Next‑Gen Treatment and Monitoring
This activity is supported by an educational grant from Genentech, a member of the Roche Group
Chart-Topping Hits: Non-Sedating Relief From Hives to Hay Fever
This activity is supported by an educational grant from Opella.
You’re on Call: Advancing to the Next Level in Pediatric EoE Care
This activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi.
A Revolution in Thyroid Eye Disease Care: Evidence, Options, and Individualized Decisions
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
Harnessing Biomarkers to Personalize Long-Term Outcomes in nAMD and DME
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
Match the Retina Master: Second-Generation Anti-VEGF Use in nAMD, DME, and RVO
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
From Weight to Integrated Metabolic Health: Strategies for Navigating Obesity, Liver Disease, and Cardiometabolic Risk
This activity is supported by an independent medical educational grant from Boehringer lngelheim Pharmaceuticals, Inc.
IBD NOW Summit for Advanced Practice Providers
This activity is supported by educational grants from AbbVie Inc.; Genentech, a member of the Roche Group; Johnson & Johnson; Lilly; and Merck & Co., Inc.
10th Annual IBD NOW Summit for Fellows
This activity is supported by educational grants from AbbVie Inc.; Genentech, a member of the Roche Group; Johnson & Johnson; Lilly; and Merck & Co., Inc.